A detailed history of Price T Rowe Associates Inc transactions in Insmed Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 12,580,981 shares of INSM stock, worth $888 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
12,580,981
Previous 12,163,368 3.43%
Holding current value
$888 Million
Previous $815 Million 12.7%
% of portfolio
0.11%
Previous 0.1%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$62.0 - $79.01 $25.9 Million - $33 Million
417,613 Added 3.43%
12,580,981 $918 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $30.7 Million - $97.2 Million
1,394,002 Added 12.94%
12,163,368 $815 Million
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $143,903 - $167,514
5,595 Added 0.05%
10,769,366 $292 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $8.35 Million - $11.3 Million
356,555 Added 3.43%
10,763,771 $334 Million
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $4.67 Million - $6.33 Million
234,920 Added 2.31%
10,407,216 $263 Million
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $3.13 Million - $4.01 Million
190,232 Added 1.91%
10,172,296 $215 Million
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $67,527 - $90,244
4,153 Added 0.04%
9,982,064 $170 Million
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $7.3 Million - $9.95 Million
429,664 Added 4.5%
9,977,911 $199 Million
Q3 2022

Nov 14, 2022

SELL
$20.88 - $28.21 $139 Million - $188 Million
-6,674,376 Reduced 41.14%
9,548,247 $206 Million
Q2 2022

Aug 15, 2022

BUY
$17.07 - $25.71 $6.22 Million - $9.37 Million
364,362 Added 2.3%
16,222,623 $320 Million
Q1 2022

May 16, 2022

BUY
$20.42 - $28.13 $11 Million - $15.1 Million
537,057 Added 3.51%
15,858,261 $373 Million
Q4 2021

Feb 14, 2022

BUY
$25.89 - $33.45 $15 Million - $19.4 Million
580,772 Added 3.94%
15,321,204 $417 Million
Q3 2021

Nov 15, 2021

BUY
$22.46 - $29.47 $8.26 Million - $10.8 Million
367,747 Added 2.56%
14,740,432 $406 Million
Q2 2021

Aug 16, 2021

BUY
$24.17 - $36.01 $74.2 Million - $111 Million
3,070,140 Added 27.16%
14,372,685 $409 Million
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $53.3 Million - $73.1 Million
1,650,241 Added 17.1%
11,302,545 $385 Million
Q4 2020

Feb 16, 2021

BUY
$31.45 - $40.54 $304 Million - $391 Million
9,652,304 New
9,652,304 $321 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.56B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.